Home > Insider Trading > Filing (0000899243-23-007331)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1704292	Zai Lab Ltd	ZLAB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835824	Harald Reinhart	C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
American Depositary Shares	Acquisiton	2023-03-03	11,480	$3.00	30,438	No	4	M	Direct
American Depositary Shares	Disposition	2023-03-03	11,480	$40.00	18,958	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
American Depositary Shares	Stock Options (Right to Buy)	Disposition	2023-03-03	11,480	$0.00	11,480	$3.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-05-12	No	4	M	Direct

Footnotes

Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 08/23/2022, that expires on 06/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
The options vest in equal installments over four years beginning on 5/12/2018, the first anniversary of the date of grant.